Tatjana Odrljin has joined Takeda Pharmaceuticals as Senior Medical Director, Clinical Development, Zika. Dr. Odrljin joins Takeda from Shire, where she served as Global Clinical Development Lead (Medical Director), Fibrotic Disorders. In addition to an MD from the University of Belgrade School of Medicine, Dr. Odrljin has held positions of increasing related responsibility at Wyeth, Novartis, and Alexion.
The search was successfully led by Julie McDonald at Westwood & Wilshire.
At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley and Connecticut, we serve our clients on a local, national and global basis.
Westwood & Wilshire, LLC
Offices in Los Angeles, Silicon Valley, Seattle, and Scottsdale
© Westwood & Wilshire LLC. All Rights Reserved.